easee, an Amsterdam-based MedTech innovator, has announced the publication of a study in Nature Digital Medicine that it says underscores the reliability of its self-administered, web-based remote refraction test as an alternative to traditional in-person eye exams—even in real-world conditions, and aims to tackle the ‘growing myopia epidemic’.
Refractive errors remain one of the most common causes of preventable visual impairment worldwide, yet are often left uncorrected due to limited access to eye care professionals, particularly in underserved communities. easee’s newly validated remote refraction approach empowers individuals to conduct vision assessments from anywhere using only a smartphone, a laptop, and internet access—offering a transformative path to broader eye care accessibility.
“Our mission is to ensure that people have the tools they need to take charge of their own eye health,” said Yves Prevoo, Founder & CEO at easee. “By providing a reliable web-based solution, we are democratising access to essential vision care—no matter where a person resides.”
Researchers analysed data from 14,680 real-world healthy eyes between the ages of 18 and 45, all with high visual acuity and low-to-moderate refractive errors. Results showed remarkable accuracy for myopia, For nearsighted participants, the mean difference between remote refraction results and conventional prescriptions was just 0.01 diopters says the company.
The results also showed High Alignment with In-Clinic Tests, as 82% of myopic users fell within ±0.75 diopters when compared to conventional prescriptions generated in-clinic.
In practice, a trained easee optometrist reviews the remote measurements, further reducing any risk of erroneous prescriptions. easee says these findings confirm that its remote testing algorithm performs impressively in real-world settings. The company says that at a time when 50% of the global population is expected to be myopic by 2050,scalable and cost-effective solutions like this have ‘never been more important.’
“This is more than just another digital health tool,” noted Dr. Robert Wisse MD PhD, Ophthalmologist and Lead author of the paper. “Our study in Nature Digital Medicine shows how remote refraction can help streamline care delivery, reduce societal burdens, and close crucial gaps in eye care worldwide.”
Building on these outcomes, easee says it plans to expand its solutions across multiple demographics and eye conditions. The technology also holds promise for assisting with post-operative cataract management, myopia management, screening programs for uncorrected refractive errors, and broader digital vision care initiatives.
